NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ELUTIA INC. Logo
Develops drug-eluting biomaterials for medical implants and tissue reconstruction.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and delivers medical countermeasures for public health threats and crises.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Biotechnology company developing small molecule drugs for virology and immunology.
United States of America
ENTA
Enervit Logo
Develops sports nutrition, functional foods, and wellness supplements.
Italy
ENV
enGene Holdings Inc. Logo
Clinical-stage biotech developing non-viral gene therapies for local delivery.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
Clinical-stage biopharma developing kinase inhibitors for precision oncology.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
A clinical-stage macrophage reprogramming immunotherapy company.
Israel
ENLV
Enlivex Therapeutics Ltd. Logo
Develops macrophage reprogramming immunotherapy for inflammatory diseases.
United States of America
ENLV
Enorama Pharma AB Logo
Develops and manufactures medicated chewing gums and tobacco-free nicotine pouches.
Sweden
ERMA
Ensol Biosciences Inc. Logo
AI-driven biopharma developing peptide drugs for unmet medical needs.
South Korea
140610

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.